Superstring Capital Management LP Protara Therapeutics, Inc. Transaction History
Superstring Capital Management LP
- $84.5 Billion
- Q2 2025
A detailed history of Superstring Capital Management LP transactions in Protara Therapeutics, Inc. stock. As of the latest transaction made, Superstring Capital Management LP holds 360,000 shares of TARA stock, worth $1.67 Million. This represents 1.29% of its overall portfolio holdings.
Number of Shares
360,000
Previous 360,000
-0.0%
Holding current value
$1.67 Million
Previous $1.53 Billion
28.87%
% of portfolio
1.29%
Previous 1.82%
Shares
1 transactions
Others Institutions Holding TARA
# of Institutions
86Shares Held
28MCall Options Held
37.2KPut Options Held
65.1K-
Janus Henderson Group PLC London, X04.1MShares$19 Million0.01% of portfolio
-
Velan Capital Investment Management LP Alpharetta, GA2.14MShares$9.92 Million11.14% of portfolio
-
Blackstone Inc New York, NY1.91MShares$8.86 Million0.03% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.8MShares$8.36 Million0.0% of portfolio
-
Acorn Capital Advisors, LLC New York, NY1.75MShares$8.13 Million3.47% of portfolio
About Protara Therapeutics, Inc.
- Ticker TARA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 11,267,400
- Market Cap $52.3M
- Description
- Protara Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the identifying and advancing transformative therapies for the treatment of cancer and rare diseases. The company's lead program is TARA-002, an investigational cell therapy for the treatment of lymphatic malformations. It also develops intravenous choline chlorid...